Undervalued Stocks Based On Cash Flows

Results

145

15 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

145 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
HBAN
US$17.03-4.9%-1.9%US$34.4bUS$20.301.225.7%3.6%Banks
HIMS
New
US$33.7820.0%-24.2%US$7.4bUS$30.853.164.1%n/aHealthcare
ALRS
US$32.77-2.7%45.8%US$811.6mUS$35.4029.640.6%2.7%Diversified Financials
SYM
US$41.83-2.0%-9.5%US$25.1bUS$64.32661.855.5%n/aCapital Goods
SPT
US$10.021.3%-34.0%US$610.2mUS$10.441.3107.1%n/aSoftware
CVI
New
US$39.5112.1%44.8%US$3.6bUS$31.4057.669.7%1.0%Energy
YOU
US$43.29-4.8%19.1%US$5.8bUS$62.6030.122.0%1.8%Software
WLTH
US$9.220.9%n/aUS$1.4bUS$12.253.785.4%n/aDiversified Financials
GSHD
New
US$72.529.4%-19.0%US$2.5bUS$68.9248.920.4%0%Insurance
J
US$150.083.7%1.1%US$17.3bUS$162.5348.928.7%1.0%Commercial Services
XERS
US$8.701.2%12.3%US$1.6bUS$11.714.755.9%n/aPharmaceuticals & Biotech
BA
US$214.20-7.5%-6.9%US$170.0bUS$274.8581.042.9%0%Capital Goods
GPC
US$133.96-0.8%-4.0%US$18.3bUS$140.38563.641.7%3.2%Retail
FLEX
US$110.45-12.5%112.7%US$40.8bUS$160.5041.944.9%n/aTech
NTRA
US$332.037.1%100.5%US$46.8bUS$336.7417.762.6%n/aPharmaceuticals & Biotech
MELI
US$1,922.734.2%-20.9%US$97.4bUS$2,256.5452.329.0%0%Retail
FORM
US$114.16-13.3%291.5%US$9.0bUS$138.6377.243.7%n/aSemiconductors
LKNC.Y
US$35.861.6%-5.3%US$11.7bUS$48.2120.623.2%n/aConsumer Services
COHR
US$289.52-11.1%222.0%US$56.8bUS$416.0973.643.9%n/aTech
ZETA
US$29.070.07%48.7%US$7.0bUS$31.364.649.1%n/aSoftware
VSXY
US$85.39-4.1%285.5%US$6.9bUS$93.6032.246.0%n/aRetail
MBLY
US$9.031.2%-36.2%US$7.5bUS$12.113.894.2%n/aAutomobiles
BE
US$201.45-12.4%315.0%US$59.6bUS$275.08242.242.5%n/aCapital Goods
QTWO
US$63.91-1.3%-19.6%US$4.0bUS$74.3643.323.1%n/aSoftware
Page 1 of 5